Seelos Therapeutics, Inc.

Ownership Transactions Reported by 6 Insiders

Symbol
SEEL on Nasdaq
Industry
Pharmaceutical Preparations
Location
300 Park Avenue, 2 Nd Floor, New York, NY

There are no Buy or Sell transactions made by insiders since 9/18/2023

Seelos Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Raj Mehra President, Chief Executive Officer and Chairman of the Board of Directors, Director $114K Jan 12, 2024
Michael Golembiewski Chief Financial Officer $95.3K Feb 29, 2024
Daniel J. O'Connor Director Jan 4, 2024
Richard W. Pascoe Director Jan 4, 2024
Margaret Dalesandro Director Jan 4, 2024
Brian Lian Director Jan 4, 2024

Recent Insider Transactions by Companies or Individuals for Seelos Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.